To solve a problem, scientists first need to see it clearly. Whether it’s a virus slipping past the immune system or plaques ...

Demis Hassabis, CEO of DeepMind, revealed that AI can drastically shorten drug discovery timelines, potentially reducing ...

To solve a problem, we have to see it clearly. Whether it's an infection by a novel virus or memory-stealing plaques forming ...

Thomas Grant secures $2.18 million grant to pioneer protein-studying tool that could lead to new and personalized medicine.

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Recursion Pharmaceuticals RXRX is redefining the traditional model of drug discovery by harnessing the power of artificial intelligence (AI) through its proprietary RecursionOS platform, developed in ...

Alex Zhavoronkov, founder and CEO of Insilico Medicine, explores how A.I. is driving drug discovery breakthroughs—and ...

The big, unopened boxes of lab equipment that crowd one room at the recently expanded Skaggs Pharmaceutical Sciences Center are a sign of things to come for drug research at the University of Arizona.

With support from EDB and A*Star, Japanese biopharma leader Chugai is using its research base in Singapore to create new ...

The potential of AI to analyse vast quantities of data in a relatively short time frame makes its application to the ...

Ubiquitin controls the lifespan and distribution of proteins in the cell, but it can also determine their shape, function, or ...

We develop cutting-edge software and AI solutions for small molecule design, optimization and data analysis. Our mission is ...